ATE387206T1 - Säure und gallensalz-resistente lactobacillus isolate, welche die fähigkeit besitzen, cholesterin zu erniedrigen oder zu assimilieren - Google Patents

Säure und gallensalz-resistente lactobacillus isolate, welche die fähigkeit besitzen, cholesterin zu erniedrigen oder zu assimilieren

Info

Publication number
ATE387206T1
ATE387206T1 AT03256350T AT03256350T ATE387206T1 AT E387206 T1 ATE387206 T1 AT E387206T1 AT 03256350 T AT03256350 T AT 03256350T AT 03256350 T AT03256350 T AT 03256350T AT E387206 T1 ATE387206 T1 AT E387206T1
Authority
AT
Austria
Prior art keywords
ability
acid
bile salt
salt resistant
cholesterol
Prior art date
Application number
AT03256350T
Other languages
English (en)
Inventor
Yu-Ju Liu
Chin-Chu Yu
Ching-Fen Tan
Chii-Cherng Liao
Original Assignee
Food Industry Res & Dev Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Food Industry Res & Dev Inst filed Critical Food Industry Res & Dev Inst
Application granted granted Critical
Publication of ATE387206T1 publication Critical patent/ATE387206T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/113—Acidophilus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/23—Lactobacillus acidophilus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AT03256350T 2002-10-30 2003-10-09 Säure und gallensalz-resistente lactobacillus isolate, welche die fähigkeit besitzen, cholesterin zu erniedrigen oder zu assimilieren ATE387206T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB021469474A CN1237168C (zh) 2002-10-30 2002-10-30 具有降低与同化胆固醇能力的耐酸与耐胆盐乳杆菌分离株

Publications (1)

Publication Number Publication Date
ATE387206T1 true ATE387206T1 (de) 2008-03-15

Family

ID=32235204

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03256350T ATE387206T1 (de) 2002-10-30 2003-10-09 Säure und gallensalz-resistente lactobacillus isolate, welche die fähigkeit besitzen, cholesterin zu erniedrigen oder zu assimilieren

Country Status (4)

Country Link
EP (1) EP1424075B1 (de)
CN (2) CN1237168C (de)
AT (1) ATE387206T1 (de)
DE (1) DE60319323T2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4626884B2 (ja) * 2005-03-14 2011-02-09 株式会社日立プラントテクノロジー 嫌気性アンモニア酸化細菌の培養方法及び装置
EP2011506A1 (de) * 2007-07-05 2009-01-07 Nestec S.A. Ergänzung zu einer Schwangerschaftsdiät
CN102108337B (zh) * 2010-07-28 2012-05-30 江南大学 一种干酪乳杆菌及其应用
CN103275921B (zh) * 2013-05-16 2015-04-15 江南大学 一种提高乳杆菌耐胆盐能力的方法
CN103289926B (zh) * 2013-05-30 2015-08-26 中国农业科学院哈尔滨兽医研究所 一株唾液乳杆菌菌株及其应用
CN103352019A (zh) * 2013-07-22 2013-10-16 扬州大学 用于发酵乳制备的嗜热链球菌grx11及应用
CN104789488B (zh) * 2014-03-09 2018-05-04 黑龙江大学 具有降胆固醇作用的鼠李糖乳杆菌及用途
CN104651268B (zh) * 2014-12-31 2018-01-09 北京博锦元生物科技有限公司 一种植物乳杆菌及其应用
KR101860552B1 (ko) 2015-04-16 2018-07-02 주식회사 고바이오랩 질 내 병원성 미생물에 대한 증식억제활성을 갖는 락토바실러스 속 균주
CN112592874B (zh) * 2021-03-04 2021-05-28 山东中科嘉亿生物工程有限公司 一种降低血液中胆固醇含量的嗜酸乳杆菌jyla-191及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH31093A (en) * 1993-08-06 1998-02-05 Nestec Ltd Lactobacillus bulgaricus having decreased acid production and/or improved aroma and flavor production and food composition comprising said lactobacillus.
EP0792586A3 (de) * 1996-02-28 1999-04-07 Unilever N.V. Nahrungmittel, die Bakterien mit cholesterolinsenkender Wirkung enthalten
SE0004124D0 (sv) * 2000-11-10 2000-11-10 Probi Ab New use

Also Published As

Publication number Publication date
CN1493684A (zh) 2004-05-05
HK1065821A1 (en) 2005-03-04
DE60319323D1 (de) 2008-04-10
CN1313600C (zh) 2007-05-02
EP1424075A2 (de) 2004-06-02
CN1237168C (zh) 2006-01-18
HK1081993A1 (en) 2006-05-26
CN1680543A (zh) 2005-10-12
DE60319323T2 (de) 2009-04-02
EP1424075B1 (de) 2008-02-27
EP1424075A3 (de) 2004-10-06

Similar Documents

Publication Publication Date Title
DE60319323D1 (de) Säure und Gallensalz-resistente Lactobacillus Isolate, welche die Fähigkeit besitzen, Cholesterin zu erniedrigen oder zu assimilieren
WO2004074232A8 (en) 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases
DE69929232D1 (de) Virusähnliche partikel zur induktion von autoantikörpern
SI1721612T1 (sl) Imunomodulirajoči oligosaharidi
DE60010702D1 (de) Behandlung von titanerz zur herstellung von titandioxidpigmenten
DE60028003D1 (de) Bifidobakterium zur behandlung von entzündungskrankheiten
WO2006062716A3 (en) Methods and compositions for treating ocular disorders
GB2460781A (en) Probiotic bifidobacterium strains
WO2004019884A3 (en) Agents and methods for enhancing bone formation
WO2003031650A3 (en) Genes and proteins for prevention, prediction, prognosis and therapy of cardiovascular disease
EP0861905A3 (de) Neuartige Lactobacillusstämme verwendbar zur Behandlung von Störugen des Magendarmsystems
HUP0400801A2 (hu) Epesavak vagy epesavas só-zsírsav konjugátumokat tartalmazó gyógyszerkészítmények és alkalmazásuk
WO2011060534A8 (en) Trim5alpha mutants and uses thereof
DE602005020178D1 (de) 5,6,7-trihydroxyheptansäure und analoge zur behandlung von augenkrankheiten und mit hyperproliferativen und angiogenen reaktionen verbundenen krankheiten
WO2007017146A3 (en) Use of collismycin and derivatives thereof as oxidative stress inhibitors
EE200300220A (et) Bifidobacterium'i perekonna probiootiliste tüvedeskriinimise meetod
WO2004111270A3 (en) Differential gene expression in schizophrenia
Bawaskar et al. Homocysteine: Often neglected but common culprit of coronary heart diseases
PL1638559T3 (pl) Zastosowanie pirazolopirydyn w leczeniu deficytów poznawczych
WO2004043397A3 (en) Compositions and methods for the treatment of rheumatoid arthritis
ATE418558T1 (de) Darstellung von 1-aza-2-oxadibenzoäe,hüazulenen und deren verwendung bei der herstellung pharmazeutischer formulierungen zur behandlung und prävention von krankheiten und erkrankungen des zentralen nervensystems
RU2002125578A (ru) Биологически активная добавка "интеллектуальные"
Clark Follow-up at Camelford.
WO2004082572A3 (en) Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 87 (gpr87)
WO2007049062A3 (en) Vwfa-domain containing proteins

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties